Loma Linda University | Loma Linda University Medical Center
Webmail | Canvas | MyLLU | People Portal
Loma Linda School of Medicine

Prospective Students | Class Registration
Call Us At: 1-909-558-1000

Main Navigation
About LLU
Schools & Programs
Libraries
Research
Outreach
Spiritual Life
Jobs
  • Basic Sciences
  • Graduate Program
    • Courses
    • MD/PhD Program
    • Program Coordinators
  • Divisions
    • Anatomy
    • Biochemistry
    • Microbiology
    • Pharmacology
    • Physiology
  • Centers
    • Health Disparities
    • Perinatal Biology
  • Core Facilities
  • Summer Research
  • Faculty
  • Administration
    • Department Administrators
    • Administrative Staff
  • Contact Us
  • Upcoming Events/Announcements
Medicine > Departments and Programs > Basic Sciences > Faculty > Faculty Profile
Profile Photo
Lincoln Edwards, DDS, PhD
Division of Pharmacology
School of Medicine
Loma Linda University
Loma Linda, CA 92350
U.S.A

Phone:(909) 558- 4000 ext. 42923
Fax:(909) 558-0119
E-mail:lpedwards@llu.edu
Lincoln Edwards, DDS, PhD
Assistant Professor
Basic Sciences
Division of Pharmacology
School of Medicine

Research Interest

As the human body continues to expand, so does the epidemic of type 2 diabetes, and novel approaches to the treatment of metabolic diseases will be needed.  My research interest involves the development of imidazoline compounds as therapeutic agents to treat metabolic disease such as type 2 diabetes.  Clinically useful imidazolines such as moxonidine have the potential to treat both hypertension and type 2 diabetes. We are interested in testing novel compounds to be used as single agent therapy for diabetics with hypertension.  We are also studying the mechanism of cross-talk between imidazoline and insulin receptor signaling pathways.

Selected Publications

1. Lincoln P. Edwards, Terry A.  Brown-Bryan,  Lancelot McLean and Paul Ernsberger. Pharmacological Properties of the Central Antihypertensive Agent, Moxonidine. Cardiovasc Ther. 2012, 30(4):199-208.

2. Tesfai J, Crane L, Baziard-Mouysset G, Edwards LP (2012) Novel I1-Imidazoline Agonist S43126 Augment Insulin Secretion in Min6 Cells. J Diabetes Metab 3:183.

3. Jerusalem Tesfai,Louis Crane, Genevieve Baziard-Mouysset and Lincoln P. Edwards. Novel I1-Imidazoline S43126 Enhance Insulin Action in PC12 Cells . Pharmacological Reports, 2011, 63, 1442-1449.

4. Lancelot S. McLean, Louis Crane, Genevieve Baziard-Mouysset and Lincoln P. Edwards. The novel imidazoline compound, S43126 induces apoptosis in PC12 cells. (submitted)

5. Lancelot S. McLean and Lincoln P. Edwards. The Association between Diabetes and Oral Cancer.. (In Preparation)

6. Terry A.  Brown-Bryan and Lincoln P. Edwards. Moxonidine Stimulates Glucose Uptake  through a IRAS-IRS dependent Signaling Pathway. (In Preparation)

7. Lincoln P. Edwards. Terry A.  Brown-Bryan,  Lancelot McLean and Paul Ernsberger. Moxonidine: An Imidazoline Agent Targeting Metabolic Syndrome. (In press).

8. Jerusalem Tesfai1,Louis Crane2, Genevieve Baziard-Mouysset2 and Lincoln P. Edwards3 Novel I1-Imidazoline S43126 Enhance Insulin Action in PC12 Cells .(in preparation).

9. Wentsworth B. Kennedy1, Louis Crane2, Ramon R. Gonzalez3, Genevieve Baziard-Mouysset4, and Lincoln. P. Edwards Characterization of S43126 an Imidazoline agonist and its involvement as an anti-hypertensive drug in rats.(in preparation).

10. Oommen K. George, ,  Ramon R. Gonzalez Jr.,,  Lancelot McLean, Raymond G. Hall, J., and  Lincoln. P. Edwards.  Angiotensin II induced tension development in rat-tail artery involves PLD and PKC Advanced Studies in Biology,  (In press)

8. Wentsworth B. Kennedy, Louis Crane, Ramon R. Gonzalez, Oommen K.George, and Lincoln. P. Edwards.   Effects of a Catecholamine and some Imidazolines on Induced Tension in Rat-Tail Artery.  Cellular and Molecular Neurobiology, 2006 Jul;26(4-6):643-55s (Special Issue in honor of Dr. Julius Axelrod, Nobel Laureate)

11.. Oommen K. George, Ramon R. Gonzalez, and Lincoln. P. Edwards (2003). Moxonidine, a selective α2-adrenergic and Imidazoline receptor Agonist, is permissive to α1-adrenergic receptor pathway in the rat-tail artery.  J. of Cardiovascular Pharmacology vol.43, number 2, February 2004.

12. Edwards,L.P., and Ernsberger, P:  The   I1-imidazoline Receptor in PC12 Pheochromocytoma Cells Reverses NGF-Induced ERK Activation and Induces MKP-2 Phosphatase.  Brain Research (2003) 980/1 pp. 71-79

13. Edwards, L., Whitter, E. and Hessinger, D.  Apparent membrane pore-formation by Portuguese Man-of-war (Physalia physalis) venom in intact cultured cells.. Toxicon 40 (2002 ) 1299-1305.

14. Edwards L, Fishman D, Horowitz P, Bourbon N, Kester M, Ernsberger P. The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK). J. Neurochem 2001 Dec1; 79(5):931-940

15. Edwards, L., and Hessinger, D.  Portuguese Man-of-war (Physalia physalis) venom induces calcium influx into cells by permeabilizing plasma membranes. Toxicon 2000 Aug; 38(8):1015-28

16. Edwards, L.P., and Ernsberger, P. (2000) Assay of Arachidonic Acid Release Coupled to α1- and α2-Adrenergic Receptors, in Methods in Molecular Biology, vol.126. (Adrenergic Receptor Protocols Curtis A. Machida editor), Humana Press, Totowa, New Jersey ,pg. 375 – 390

17. Edwards, L., Luo, E., Hall, R., Gonzalez Jr.,R.R. and Hessinger, D.A.  The Effect of Portuguese Man-of-war (Physalia physalis) venom on calcium, sodium and potassium fluxes of cultured embryonic chick heart cells.  Toxicon (2000)Mar; 38(3): 323-335

 

 



 
© 2013 Loma Linda University 1-909-558-1000 | Parking, Maps & Directions | Contact us
Loma Linda University Adventist Health Sciences Center | University | Medical Center
Jobs | Support Loma Linda | Media Resources | Spiritual Life | Research
Privacy Information | Website Feedback